The primary impact of using the covalidation model is the expedited analytical method qualification of both the transferring and receiving laboratories.
Yueer Shi
Advertisement
Yueer Shi is group leader, Bristol Myers Squibb, USA, yueer.shi@bms.com
Articles by Yueer Shi
Advertisement
Latest Updated Articles
Covalidation Strategies to Accelerate Analytical Method Transfer for Breakthrough TherapiesPublished: April 2nd 2017 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Using AI and Molecular Dynamics to Overcome the Poor Solubility Challenge
2
Why Context Matters in Validating Biomarker Assays for Bioanalysis
3
An approach to streamline and simplify the identification of crucial metabolites from targeted protein degraders
4
Targeted high resolution metabolite screening workflows
5
